IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026)
IM Cannabis' (IMCC) quarterly Total Current Liabilities came in at $20.2 million in Q1 2026, down 28.9% year-on-year from $28.4 million in Q1 2025, and down 17.11% quarter-over-quarter from $24.4 million in Q4 2025.
IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $20.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 28.9% year-over-year to $20.2 million in Q1 2026; TTM through Mar 2026 was $20.2 million, a 28.9% decrease from a year earlier, with the FY2025 full-year figure at $24.4 million, down 4.39% from the prior year.
- Total Current Liabilities eased to $20.2 million in Q1 2026 per IMCC's latest filing, from $24.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $53.1 million in Q3 2022 and bottomed at $19.3 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $24.9 million (2022), against an average of $28.0 million.
- Across the five-year window, Total Current Liabilities surged 98.41% in 2022 and sank 60.66% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $24.9 million in 2022, then retreated by 3.16% to $24.1 million in 2023, then rose by 3.6% to $25.0 million in 2024, then retreated by 2.44% to $24.4 million in 2025, then fell by 17.11% to $20.2 million in 2026.
- Per Business Quant, the three latest IMCC Total Current Liabilities figures stand at $20.2 million (Q1 2026), $24.4 million (Q4 2025), and $27.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 20.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.21 Mn |
| Dec 31, 2025 | 24.39 Mn |
| Sep 30, 2025 | 27.95 Mn |
| Jun 30, 2025 | 25.37 Mn |
| Mar 31, 2025 | 28.43 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 28.77 Mn |
| Jun 30, 2024 | 24.42 Mn |
| Mar 31, 2024 | 22.62 Mn |
| Dec 31, 2023 | 24.13 Mn |
| Sep 30, 2023 | 20.89 Mn |
| Jun 30, 2023 | 20.92 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 24.91 Mn |
| Sep 30, 2022 | 53.09 Mn |
| Jun 30, 2022 | 42.01 Mn |
| Mar 31, 2022 | 43.51 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Sep 30, 2021 | 26.76 Mn |
| Dec 31, 2020 | 4.81 Mn |